These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3908781)

  • 21. [Excretion of catecholamines in patients with obliterating arteriosis before and after complex conservative treatment].
    Mikeladze NA
    Klin Khir (1962); 1974 Jul; 7(0):21-5. PubMed ID: 4848703
    [No Abstract]   [Full Text] [Related]  

  • 22. [Medical treatment of obliterating peripheral arteriopathies, especially arteriosclerosis].
    Scaffidi V
    Minerva Med; 1975 Jan; 66(2):55-65. PubMed ID: 1113917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the differential diagnosis of arterial obliterating diseases of the upper extremities].
    Hofmeister L
    Munch Med Wochenschr; 1969 May; 111(22):1259-64. PubMed ID: 5819096
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results of long-term dispensary anticoagulant therapy in patients with myocardial infarct and peripheral arteriosclerosis].
    Heine H; Schmidt H; Jahn E; Kornotzki M
    Z Gesamte Inn Med; 1973 Jan; 28(2):27-30. PubMed ID: 4632545
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of vazaprostan in the treatment of multifocal peripheral obliterating lesions of arteries of the lower limbs].
    Driuk NF; Mishalov VG; Pavlichenko LN
    Klin Khir (1962); 1994; (10):26-8. PubMed ID: 7602901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention and therapy of peripheral arteriosclerotic circulatory disorders using anticoagulants].
    Egghart F
    Wien Med Wochenschr; 1973 Apr; 123(16):259-60. PubMed ID: 4701667
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of thrombosis: current status and prospects].
    Neri Serneri GG
    Cardiol Prat; 1976; 27(2):71-6. PubMed ID: 829041
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinico-biological evaluation of the effect of Triflusal in arteriosclerotic patients with a high risk of thrombosis. A long-term study].
    Sala-Planell E; Latorre J; Marinel-lo J; Rutllant ML; Miralles J; Ramírez de Avellano R
    Angiologia; 1981; 33(2):71-8. PubMed ID: 7235297
    [No Abstract]   [Full Text] [Related]  

  • 29. [Problems in the use of anticoagulants in severe arterial occlusive diseases of the limbs].
    Linke H
    Z Gesamte Inn Med; 1970 Aug; 25(15):688-93. PubMed ID: 5527533
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of patients with obliterative diseases of arteries of the lower extremities by intra-arterial administration of the drugs].
    Bogoev DN; Voskanian EA
    Khirurgiia (Mosk); 1979 Jan; (1):64-7. PubMed ID: 759703
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevention and therapy with anticoagulants. Indications, experiences, results].
    Bruhn HD
    Intensivmed Prax; 1979; (2):91-7. PubMed ID: 553881
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticoagulation in coronary heart disease: heparin and warfarin trials.
    Lopez LM; Mehta JL
    Cardiovasc Clin; 1987; 18(1):215-29. PubMed ID: 2955891
    [No Abstract]   [Full Text] [Related]  

  • 33. [Secondary prevention following myocardial infarction--results of long-term studies].
    Berndt H
    Z Arztl Fortbild (Jena); 1983; 77(2):52-8. PubMed ID: 6132502
    [No Abstract]   [Full Text] [Related]  

  • 34. [Medical and surgical therapeutic indications in peripheral arterial obliterations caused by arteriosclerosis].
    Fontaine R; Fontaine JL
    Minerva Med; 1967 Dec; 58(101):4648-55. PubMed ID: 6082165
    [No Abstract]   [Full Text] [Related]  

  • 35. [The results of the drug therapy of the ischemic syndrome in arteriosclerosis obliterans].
    Prokhorov GG; Potapov VV; Ogneva NS; Zybina NN
    Vestn Khir Im I I Grek; 1994; 152(1-2):30-4. PubMed ID: 7701736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant medical therapy to improve patency rate following reconstruction for atherosclerosis obliterans (ASO).
    Lepäntalo M
    Acta Chir Scand Suppl; 1990; 555():51-8. PubMed ID: 2195832
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anginin (pyridinol carbamate) therapy of coronary atherosclerosis and obliterating atherosclerosis of the arteries of the lower extremities].
    Liusov VA; Belousov IuB; Martynov AI; Koroleva SA; Zimin VS
    Kardiologiia; 1972 Nov; 12(11):39-45. PubMed ID: 4655879
    [No Abstract]   [Full Text] [Related]  

  • 38. [Symposium: Arteriosclerosis (with special reference to thrombosis and anticoagulants). 4. Ischemia in brain. heart and kidnev and anticoagulants].
    HAYASE M
    Jpn J Med Sci Biol; 1962 Oct; 51():864-8. PubMed ID: 13953259
    [No Abstract]   [Full Text] [Related]  

  • 39. [Further trials of a long-acting vasodilator agent in 397 patients with cronic peripheral obliterating arteriopathy of a sclerotic nature].
    Ghezzi P; Cavaliere P; Berti Riboli E
    Minerva Cardioangiol; 1969 May; 17(5):333-6. PubMed ID: 5785731
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of acute arterial occlusion].
    Schnell D
    Ther Ggw; 1966 Aug; 105(8):1002-5. PubMed ID: 5921256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.